Australian Clinical Labs Limited (ASX:ACL)
Australia
· Delayed Price · Currency is AUD 2.800
+0.080 (2.94%)
Jun 27, 2025, 4:10 PM AEST
Australian Clinical Labs Market Cap
Australian Clinical Labs has a market cap or net worth of 530.56 million as of June 27, 2025. Its market cap has increased by 4.59% in one year.
Market Cap
530.56M
Enterprise Value
824.71M
Revenue
728.27M
Ranking
n/a
PE Ratio
17.78
Stock Price
2.80
Market Cap Chart
Since May 14, 2021, Australian Clinical Labs's market cap has decreased from 690.27M to 530.56M, a decrease of -23.14%. That is a compound annual growth rate of -6.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 544.17M | -20.50% |
| Dec 31, 2024 | 684.50M | 18.13% |
| Dec 29, 2023 | 579.45M | -3.17% |
| Dec 30, 2022 | 598.41M | -52.18% |
| Dec 31, 2021 | 1.25B | 81.29% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 115.46B |
| Pro Medicus | 29.18B |
| Cochlear | 19.32B |
| Sonic Healthcare | 12.56B |
| Telix Pharmaceuticals | 8.23B |
| Ramsay Health Care | 8.19B |
| Ansell | 4.35B |
| Regis Healthcare | 2.34B |